Golden Throat Holdings Group Company Limited (HKG:6896)
3.140
-0.020 (-0.63%)
At close: Feb 13, 2026
HKG:6896 Revenue
Golden Throat Holdings Group Company had revenue of 319.22M CNY in the half year ending June 30, 2025, a decrease of -33.45%. This brings the company's revenue in the last twelve months to 979.71M, down -2.64% year-over-year. In the year 2024, Golden Throat Holdings Group Company had annual revenue of 1.19B with 23.26% growth.
Revenue (ttm)
979.71M CNY
Revenue Growth
-2.64%
P/S Ratio
2.16
Revenue / Employee
1.16M CNY
Employees
842
Market Cap
2.32B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 223.63M | 23.26% |
| Dec 31, 2023 | 961.38M | -30.64M | -3.09% |
| Dec 31, 2022 | 992.01M | 171.47M | 20.90% |
| Dec 31, 2021 | 820.54M | 173.60M | 26.83% |
| Dec 31, 2020 | 646.94M | -150.19M | -18.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chia Tai Enterprises International | 4.42B |
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.53B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| JBM (Healthcare) | 812.98M |
| Hua Medicine (Shanghai) | 406.16M |